FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:312-313 July 19, 2007 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

(Developments in Ophthalmology. Vol. 39.) Edited by Gabriele E. Lang. 169 pp., illustrated. Basel, Switzerland, Karger, 2007. $180. ISBN 978-3-8055-8243-8.

Laser treatment has been available for more than 30 years, yet diabetic retinopathy remains the most important cause of visual loss among people of working age in developed countries — and increasingly in developing countries. Not surprisingly, a great effort is under way to find new ways to diagnose and treat this condition.

The editor and authors of this slim book set out to explain some of the pathogenic mechanisms that underlie diabetic retinopathy, new methods of assessment, new techniques for known methods of treatment, and new and possibly more effective treatments. Three chapters address macular edema, the most common . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.